Peer Review History
| Original SubmissionApril 5, 2023 |
|---|
|
PONE-D-23-09742 Integration of extreme risk protection orders into the clinical workflow: qualitative comparison of clinician perspectives PLOS ONE Dear Dr. Conrick, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Overall, the reviewers and I thought your article was very well done and a timely addition to knowledge on implementation of ERPOs. There are a few things that you should focus on in revision. First, think about how some of your examples tend to present a perception that most clinicians would not want to be involved in ERPOs, which I think is not your finding, but how the paper reads. Second, please address whether your sample excluded or included mental health clinicians per the query from reviewer 2. This then leads to a need to comment on the acceptance or lack thereof by mental health clinicians compared to other disciplines. Please submit your revised manuscript by Jul 03 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, James Curtis West, M.D. Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: “This publication was supported by the National Center For Advancing Translational Sciences of the National Institutes of Health under Award Number TL1TR002318 (to KMC). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This study was supported by funds from the State of Washington to the Firearm Injury & Policy Research Program.” Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 4. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for the opportunity to review this manuscript, in which the authors conducted a large scale study of clinician attitudes towards ERPO in WA. Overall, this is a very helpful analysis of perceived barriers and potential facilitators. My comments are very superficial. To the unfamiliar reader, the paper overall gives the impression that WA clinicians are generally against ERPO, listing many problems with the laws. In fact, as this study teams’ other papers have shown, the majority of WA clinicians are very willing to file ERPOs or to work with other parties to file for them (Gause et al 2022 in Prev Med). I would suggest dedicating another sentence or two in discussion to the fact that despite these perceived barriers, MOST clinicians do want to engage in ERPO (the authors can cite themselves here). These facilitators would add to this, but even without them in place, these ERPOs are clearly desired tools. In the Conclusions section, the authors mention that responses varied across practice setting etc. However, although they referenced differences in provider type regularly, practice setting does not seem to come up in distinguishing responses across barrier/facilitator domains. Maybe it would be helpful to provide a table that not only characterized the respondents by provider type (As is done in text) but by practice setting and anything else appropriate for an opening table (years of experience, sex, whatever else was captured in the survey) and then refer to practice setting among these other things throughout results in order to illustrate any differences in attitudes that may exist. This is not an essential, but would help readers make the most sense of the findings. Very minor points: Line 55 (“more than 90%”): The cited study found ‘89.6%’ fatality rate, so it would be more accurate to just say “90%” or “about 90%” rather than “more than 90%”. One quote is used twice. With thousands of respondents, it shouldn’t be too hard to find a different quote to use for one of the examples. “We have a constitutional right to keep and bear arms, though public and personal safety are also key. Mentally ill people already carry so much stigma I wonder if this would help or make it worse? Also, no contact orders frequently fail to prevent contact and there are other means of obtaining firearms than through legitimate sources so would an ERPO really be effective?” Overall, this is a great paper, and it adds to our understanding of barriers to ERPOs and potential ways to circumnavigate them. Reviewer #2: This study used a qualitative approach to examine the clinical perspectives of Extreme Risk Protection Orders (ERPO) in clinical care in Washington State. The sample consisted of 4,242 license physicians, nurse practitioners, and social workers in Washington State who responded to a survey distributed between May – July, 2021. There is a paucity of research on the effects of ERPOs, which may inform the development of interventions to prevent firearm-related injury and death. A main limitation in the study is the results are not generalizable to clinicians in other states where ERPOs laws may differ, and psychologists and other mental health providers were not included in the sample; however, this study fills a research gap, is very timely, and an important topic. The following major revision may improve the manuscript: Abstract: Page 2, Line 32. Please mention how the survey was conducted either online or by mail. Introduction: Page 3, Line 49. Please define the term firearm-related harm prior to using throughout the manuscript. Harm is a broad term that can refer to self-harm, suicidal behaviors, injuries, death, ect… Page 4, Line 72. Is this true for other states? This reference only refers to Washington State. Additionally, screening for access to lethal means is standard procedure in military populations. Page 4, Lines 86, 87 This sentence is a repeat from above. Page 4, Line 87. Clearly state the objective of the study here, which is to better understand the barriers to ERPOs use and the utilization of ERPOs in Washington State as reported by physicians, social workers and nurse practitioners. Methods Design Overview: Page 5, Line 96. Please include more detail of the original study in addition to the citation of the broader study, in this manuscript. Participants and Procedures: Page 5, Line 104. Please explain the rationale for the exclusion of psychologists and other mental health providers, who also serve those at highest risk of firearm related suicide. Page 6, Line 122. The response rates for physicians (25%) ARNPs (24%) and social workers (30%) are low and need to be addressed in the limitations. How does non-response bias the findings? Results Page 7, Line 147. Please explain what this statement means … “ of who should do so.” Page 7, Lines 149-153. Fig 1. Conceptual Model of Findings: Please format the lines 150-153. It may be clearer to the reader to state how each facilitator addresses each barrier rather than stating “ facilitators to the barrier ” Page 10, Lines 192-193. It will be important to emphasize the need for more research on ERPOs effectiveness in the future. Page 11, Lines 197-199. Please explain this statement and how ERPOs are related to this specific situation? Discussion: Please mention these additional limitations: the political views of the participants could not be controlled for in descriptive qualitative analyses, and the effects of the pandemic were not assessed. The low response rate and response bias also need to be addressed. Tables: Please format the tables according to the journal requirements. Please add the n for each table in the title. Footnotes should be single-spaced and in a smaller font. Table 1, 2 and Fig. 1: n should be added and italicized ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Integration of extreme risk protection orders into the clinical workflow: qualitative comparison of clinician perspectives PONE-D-23-09742R1 Dear Dr. Conrick, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, James Curtis West, M.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-23-09742R1 Integration of extreme risk protection orders into the clinical workflow: qualitative comparison of clinician perspectives Dear Dr. Conrick: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. James Curtis West Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .